GlucoTrack to issue warrants for 406,198 shares in private placement
GCTK•GlucoTrack agreed to issue warrants for 406,198 common shares in exchange for holder waivers. The warrants have a $7.50 exercise price, expire five years after issuance and require stockholder approval before exercise.
1. Warrant terms
GlucoTrack agreed on October 13, 2026, to issue unregistered warrants to purchase 406,198 common shares in exchange for holder waivers. The waivers remove share issuance restrictions; adjustments to the exercise price for variable-rate transactions are waived only for existing warrants held by signatories.
2. Approval and limits
Exercise of the new warrants requires stockholder approval of the underlying share issuance and is subject to a 9.99% beneficial ownership limit. Adjustments to their exercise price have a floor of 20% of the common stock’s closing sale price on the issuance date.
